Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
report tags : Genetown save search
Gilead Sciences Publishes 2023 ESG Impact Report
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
gilead report sciences impact esg
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024Conference call scheduled for 4:30 p.m. Eastern Time
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ARDX | $6.5 0.93% 0.92% 5.6M
|
Health Technology
|
| O: -2.97%
H: 0.61%
C: -1.38%
first report for financial results
VBI Vaccines Reports Full Year 2023 Financial Results
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
VBIV | $0.6396 1.57% 1.55% 160K
|
Health Technology
|
| O: -3.45%
H: 14.29%
C: 10.71%
year financial results
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: 1.68%
H: 1.65%
C: -4.13%
nasdaq grants
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
OCUL | $5.22 -10.92% -12.26% 9.1M
|
Health Technology
|
| O: -9.56%
H: 2.44%
C: 2.25%
nasdaq ocular global grants
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-25 (Crawled : 23:00) - biospace.com/
STOK | $12.08 3.69% 3.56% 1M
|
Health Technology
|
| O: -0.16%
H: 8.11%
C: 3.34%
year therapeutics financial results
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
Published: 2024-03-22 (Crawled : 12:30) - biospace.com/
XBIO | $4.14 7.32% 770
|
Health Technology
|
| O: -7.59%
H: 8.6%
C: 5.75%
year financial results
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - March 18, 2024
Published: 2024-03-18 (Crawled : 12:00) - biospace.com/
EYPT | $17.665 0.94% 0.93% 1.5M
|
Health Technology
|
| O: 0.09%
H: 1.91%
C: -0.93%
nasdaq pharmaceuticals grants
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
Published: 2024-03-15 (Crawled : 23:00) - biospace.com/
BFRI | $1.67 -0.59% 66K
|
|
| O: 0.0%
H: 0.0%
C: -11.43%
business year update financial results
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-02-29 (Crawled : 23:00) - biospace.com/
AKLI | $0.239 2.93% 2.85% 50K
|
|
| O: -2.6%
H: 1.46%
C: -5.36%
business year update financial results
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 13:00) - biospace.com/
RPTX 4 | $3.14 3.97% 3.82% 220K
|
Health Technology
|
| O: -2.7%
H: 4.32%
C: 1.85%
business year update therapeutics financial results
Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-02-28 (Crawled : 13:00) - biospace.com/
SNSE | $1.03 4.79% 4.57% 24K
|
|
| O: 9.09%
H: 3.57%
C: 0.0%
business year financial results
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-22 (Crawled : 17:00) - biospace.com/
AMLX A | $1.88 -5.05% -5.32% 2.5M
|
|
| O: 8.1%
H: 19.34%
C: 12.02%
year pharmaceuticals financial results
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity
Published: 2024-02-15 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.16%
H: 1.48%
C: 0.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -8.62%
H: 2.18%
C: -1.71%
year pharmaceuticals financial results
Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results
Published: 2024-02-14 (Crawled : 00:00) - biospace.com/
POCI | $5.5 0.0% 2.4K
|
Manufacturing
|
| O: 4.1%
H: 0.16%
C: -0.66%
precision year financial results
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-13 (Crawled : 18:00) - biospace.com/
BRKR | $77.725 -1.06% -1.07% 1.3M
|
Health Technology
|
| O: 5.76%
H: 7.06%
C: 2.84%
year financial results
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2024
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
INZY | $4.5 -1.75% -1.78% 590K
|
Health Technology
|
| O: 0.0%
H: 2.45%
C: 2.08%
pharma nasdaq grants
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 2, 2024
Published: 2024-02-02 (Crawled : 14:00) - biospace.com/
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: -1.14%
H: 3.34%
C: -2.19%
nasdaq pharmaceuticals grants
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024Conference call scheduled for 4:30 p.m. Eastern Time
Published: 2024-02-01 (Crawled : 22:00) - biospace.com/
ARDX | $6.5 0.93% 0.92% 5.6M
|
Health Technology
|
| O: 1.72%
H: 5.29%
C: 4.62%
report year financial results
Sage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024
Published: 2024-01-31 (Crawled : 22:00) - biospace.com/
SAGE | $13.35 2.42% 2.36% 1.3M
|
Health Technology
|
| O: -0.12%
H: 2.82%
C: -0.89%
report year therapeutics financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.